| An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent S Bhattacharya, A Rathore, D Parwani, C Mallick, V Asati, S Agarwal, ... European Journal of Medicinal Chemistry 204, 112523, 2020 | 30 | 2020 |
| Current insights into the chemistry and antitubercular potential of benzimidazole and imidazole derivatives D Parwani, S Bhattacharya, A Rathore, C Mallick, V Asati, S Agarwal, ... Mini Reviews in Medicinal Chemistry 21 (5), 643-657, 2021 | 21 | 2021 |
| Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents S Bhattacharya, V Asati, M Mishra, R Das, V Kashaw, SK Kashaw Journal of Molecular Structure 1227, 129511, 2021 | 20 | 2021 |
| The recent development of piperazine and piperidine derivatives as antipsychotic agents A Rathore, V Asati, SK Kashaw, S Agarwal, D Parwani, S Bhattacharya, ... Mini Reviews in Medicinal Chemistry 21 (3), 362-379, 2021 | 16 | 2021 |
| In-silico studies for the development of novel RET inhibitors for cancer treatment S Bhattacharya, V Asati, A Ali, A Ali, GD Gupta Journal of Molecular Structure 1251, 132040, 2022 | 7 | 2022 |
| Recent Updates on Indole Derivatives as Kinase Inhibitors in the Treatment of Cancer V Asati, R Bhupal, S Bhattacharya, K Kaur, GD Gupta, A Pathak, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2023 | 4 | 2023 |
| Breakpoint cluster region Abelson kinase inhibitors S Bhattacharya, V Asati, A Ali Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy, 37-43, 2024 | | 2024 |
| Recent updates of Indole derivatives as Kinase inhibitor in the treatment of cancer DKM Vivek Asati, Ritu Bhupal, Sushant Bhattacharya, Kamalpreet Kaur, GD ... Anticancer Agents in Medicinal Chemistry 22 (20), 2022 | | 2022 |
Vivek AsatiISF College of Pharmacy, Moga在 isfcp.org 的电子邮件经过验证
